Home›Companies›Biotech & Pharma›Modulate Bio

Modulate Bio Inc.

Develops medicines for people with neurological disorders, including essential tremor and epilepsy.

Updated Nov 10, 2026·Latest SEC filing Apr 7, 2026·Suggest an edit

About Modulate Bio

Modulate Bio is a private company based in Allston, Massachusetts, incorporated in 2023 in Delaware. It has reported $785,320 raised in one offering on Form D since June 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 11, 2024Jun 13, 2024amended Apr 7, 2026$785,320of $1.0M target10$78,532OptionsRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Modulate Bio's Form D filed Apr 7, 2026.

DD
Dario Doller
Executive officer, director and promoter
AT
Andrew Thomson
President and director

Sources

  1. SECModulate Bio Inc. Form D/A, filed Jun 12, 2025
  2. SECModulate Bio Inc. Form D, filed Jun 13, 2024
  3. SECModulate Bio Inc. filing history
  4. InvestorPalo Santo: Modulate Bio